PEP-Therapy
Prior to joining PEP-Therapy in 2014, Jennifer worked as a Consultant within the innovation financing division of a consulting firm, and then served as a Project Manager in a nanotech start-up. She has 12 years of experience in project management, innovation strategy and financing, and start-up development.
Jennifer holds an engineering degree in chemistry, a Ph.D. in molecular biology combined with an MBA.
This person is not in any teams
This person is not in any offices
PEP-Therapy
PEP-Therapy is a French biotechnology company developing first-in-class peptides as targeted therapies in oncology based on the Company’s innovative Cell-Penetrating and Interfering Peptides (CP&IP) technology.